Louis McMahon

1.4k total citations · 1 hit paper
11 papers, 1.1k citations indexed

About

Louis McMahon is a scholar working on Transplantation, Molecular Biology and Pharmacology. According to data from OpenAlex, Louis McMahon has authored 11 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Transplantation, 3 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Louis McMahon's work include Renal Transplantation Outcomes and Treatments (6 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Louis McMahon is often cited by papers focused on Renal Transplantation Outcomes and Treatments (6 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Louis McMahon collaborates with scholars based in Switzerland, United States and Canada. Louis McMahon's co-authors include Heidi A. Lane, Rachel Bikoff, James Brugarolas, Raanan Berger, Phillip G. Febbo, Qi Xue, Massimo Loda, Pradip K. Majumder, Judith Manola and Todd R. Golub and has published in prestigious journals such as Nature Medicine, American Journal of Transplantation and Rapid Communications in Mass Spectrometry.

In The Last Decade

Louis McMahon

11 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

2004 781 citations Pradip K. Majumder, Phillip G. Febbo et al. Nature Medicine profile →

Peers

Countries citing papers authored by Louis McMahon

Since Specialization

Citations

This map shows the geographic impact of Louis McMahon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis McMahon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis McMahon more than expected).

Fields of papers citing papers by Louis McMahon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louis McMahon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis McMahon. The network helps show where Louis McMahon may publish in the future.

Co-authorship network of co-authors of Louis McMahon

This figure shows the co-authorship network connecting the top 25 collaborators of Louis McMahon. A scholar is included among the top collaborators of Louis McMahon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis McMahon. Louis McMahon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Comparative pharmacokinetics of RAD001 (everolimus) in normal and tumor-bearing rodents 2009 ·Cancer Chemotherapy and Pharmacology ·Terence O’Reilly, Paul M.J. McSheehy, R. Kawai, Olivier Kretz, Louis McMahon, Joseph Brueggen, Armin Bruelisauer, Hans-Peter Gschwind, Peter R. Allegrini, Heidi A. Lane	55
2	Effect of increasing intraperitoneal infusion rates on bupropion hydrochloride-induced seizures in mice 2008 ·Annals of General Psychiatry ·Peter H. Silverstone, Robert B. Williams, Louis McMahon, (unknown), (unknown)	4
3	Convulsive liability of bupropion hydrochloride metabolites in Swiss albino mice 2008 ·Annals of General Psychiatry ·Peter H. Silverstone, Robert B. Williams, Louis McMahon, (unknown), (unknown)	25
4	Alcohol significantly lowers the seizure threshold in mice when co-administered with bupropion hydrochloride 2008 ·Annals of General Psychiatry ·Peter H. Silverstone, Robert B. Williams, Louis McMahon, (unknown), (unknown)	12
5	mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways breakdown → 2004 ·Nature Medicine ·Pradip K. Majumder, Phillip G. Febbo, Rachel Bikoff, Raanan Berger, Qi Xue, Louis McMahon, Judith Manola, James Brugarolas, Timothy J. McDonnell, Todd R. Golub, Massimo Loda, Heidi A. Lane, William R. Sellers	781
6	Clinical Development of an Everolimus Pediatric Formulation: Relative Bioavailability, Food Effect, and Steady‐State Pharmacokinetics 2003 ·The Journal of Clinical Pharmacology ·John M. Kovarik, Adele Noè, (unknown), Louis McMahon, Wayne Langholff, (unknown), Peter F. Hoyer, Robert B. Ettenger, Christiane Rordorf	23
7	Pharmacokinetics of an Everolimus-Cyclosporine Immunosuppressive Regimen Over the First 6 Months After Kidney Transplantation 2003 ·American Journal of Transplantation ·John M. Kovarik, Bruce Kaplan, Hélio Tedesco‐Silva, Barry D. Kahan, Jacques Dantal, Louis McMahon, (unknown), (unknown), Christiane Rordorf	50
8	Administration diluents differentiate Neoral from a generic cyclosporine oral solution 2002 ·Clinical Transplantation ·John M. Kovarik, (unknown), Louis McMahon, Yibin Wang, James C. Kisicki, Robert Schmouder	8
9	Single‐dose pharmacokinetics and tolerability of everolimus in stable pediatric renal transplant patients 2002 ·Pediatric Transplantation ·(unknown), Nicholas J.A. Webb, Peter F. Hoyer, John D. Mahan, Jacques M. Lemire, Robert B. Ettenger, Louis McMahon, (unknown), R. Boger, John M. Kovarik, (unknown)	27
10	High‐throughput semi‐automated 96‐well liquid/liquid extraction and liquid chromatography/mass spectrometric analysis of everolimus (RAD 001) and cyclosporin a (CsA) in whole blood 2001 ·Rapid Communications in Mass Spectrometry ·Nastry Brignol, Louis McMahon, (unknown), Francis L. S. Tse	67
11	High-throughput analysis of everolimus (RAD001) and cyclosporin A (CsA) in whole blood by liquid chromatography/mass spectrometry using a semi-automated 96-well solid-phase extraction system 2000 ·Rapid Communications in Mass Spectrometry ·Louis McMahon, (unknown), Michael Hayes, Francis L. S. Tse	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact